Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NeoMTA Plus
- Development stage
- Unknown
- Lead developer
- NuSmile
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Topical
01
Overview
NeoMTA Plus is a bioactive, tricalcium silicate-based bioceramic dental cement developed and manufactured by Avalon Biomed. It is designed for use in various endodontic procedures, including pulpotomies, pulp capping, root-end fillings, and as an endodontic sealer. As a refined version of Mineral Trioxide Aggregate (MTA), it utilizes tantalum oxide as a radiopacifier instead of bismuth oxide to prevent tooth discoloration, a common issue with earlier MTA formulations. The material is known for its high alkalinity, release of calcium ions, and ability to promote the formation of hydroxyapatite, which facilitates the healing of dental pulp and the formation of a protective mineralized barrier. Clinical evaluations, including those conducted by Texas A&M University Baylor College of Dentistry, have focused on its color stability and efficacy in primary teeth compared to traditional treatments like formocresol.
- Brand names
- NeoMTA Plus
- Other names
- NeoMTANeoMTA-Texas A & M University Baylor College Of Dentistry
Beyond the preview
Go deeper on NeoMTA Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeoMTA Plus.